MD, University of Hamburg, University Medical Center Hamburg-Eppendorf, Germany
Internal Medicine - Icahn School of Medicine at Mount Sinai, Mount Sinai St. Luke’s and Mount Sinai West
I became interested in the field of oncology due to the importance of the patient-doctor relationship. This aspect of healthcare is necessary and is as important as the medical treatment itself. As a physician, I look to support my patients in all facets of their treatment. When I am caring for patients, I use the principle of integrative medicine. Through this method, I focus on the patient as a whole and not just the disease they face. Continuing to improve my skills is of the utmost importance to me so that I can provide care using the latest advances and at the highest level.
Awards and Honors
The German National Merit Foundation Scholarship (Studienstiftung des Deutschen Volkes) (2010)
The Roggenbuck-Foundation Scholarship, Research Project Scholarship at Harvard Medical School (2009)
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Liubou Uslar discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at email@example.com.